Alyftrek
RxNorm concept 2701439, brand name (bn).
- RxCUI
- 2701439
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2701439 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG [Alyftrek] (SBDC, ingredient of)
- Alyftrek Oral Product (SBDG, ingredient of)
- Alyftrek Pill (SBDG, ingredient of)
- deutivacaftor / tezacaftor / vanzacaftor Oral Tablet [Alyftrek] (SBDF, ingredient of)
- deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet [Alyftrek] (SBD, ingredient of)
- deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG [Alyftrek] (SBDC, ingredient of)
- deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek] (SBD, ingredient of)
- tezacaftor (IN, tradename of)
- deutivacaftor (IN, tradename of)
- vanzacaftor (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2701439 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2701439 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2701439. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.